ArticleFrontiers in endocrinology2026
Pre-pregnancy BMI modifies the optimal interpregnancy interval for preventing preterm birth: a population-based retrospective cohort study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate whether pre-pregnancy body mass index (BMI) modifies the association between interpregnancy interval (IPI) and preterm birth (PTB) risk and to determine the BMI-specific IPI associated with the lowest PTB risk. Methods: This population-based retrospective cohort study utilized data from 127,542 multiparous women in Dongguan, China (2014-2024). We employed two complementary approaches: a generalized additive mixed model and generalized estimating equations with restricted cubic splines, to examine the interaction between IPI and pre-pregnancy BMI on PTB. The robustness of the findings was evaluated through inverse probability weighting and subgroup analyses. Results: Pre-pregnancy BMI significantly modified the IPI-PTB association. A clear inverse relationship was observed, whereby the IPI associated with the lowest PTB risk shortened progressively as BMI increased. The adjusted IPI associated with the lowest PTB risk decreased from 38.8 months (95% CI: 32.0-60.0) among underweight women to 32.4 months (29.7-37.2) for normal weight and 26.7 months (6.0-30.8) for overweight. For women with obesity, within the studied range (IPI ≥ 6 months), the lowest risk was observed at the shortest interval (6.0 months), although the wide 95% confidence interval (6.0-60.0) and the exclusion of IPIs Conclusion: This study provides evidence that pre-pregnancy BMI is an important effect modifier of the IPI-PTB relationship. The finding that the IPI associated with the lowest PTB risk shortens with increasing BMI indicates that the relationship between interpregnancy interval and preterm birth varies by maternal BMI. Although causal inference cannot be drawn from this observational study, the results suggest that uniform IPI guidelines may warrant re-examination across BMI categories.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.